Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
EmailIphone Application    Posted: 11th February 2021
If you would like to forward this story on to a friend, simply fill in the form below and click send.
Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Vetoquinol acquires Canadian rights to Profender®
"The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment" - Matthieu Frenchin, CEO of Vetoquinol.
Product family encompasses a range of spot-on solutions for cats

Animal health company Vetoquinol has announced the acquisition of the Canadian rights to the Profender® product family from Elanco Animal Health.

The move follows the firm's acquisition of Profender® and Drontal® product families, in relation to Elanco's 2020 acquisition of Bayer Animal Health. In January 2021, Vetoquinol also acquired the Profender® and Drontal® product families in Australia.

Commenting on the acquisition, Matthieu Frechin, CEO of Vetoquinol, said: "We are very pleased to acquire Profender® for the Canadian market, one of our prominent strategic countries. 

“The acquisition of this strong brand for the Canadian market confirms our ambition to become a major player in the parasiticide segment. Adding this essential to our product portfolio in Canada will strengthen our market share in the pet segment in this strategic country.” 

The Profender® family of products encompasses a range of spot-on solutions for cats.

 

Become a member or log in to add this story to your CPD history

Equine Disease Surveillance report released for Q4 2025

News Story 1
 The latest Equine Disease Surveillance report has been released, with details on equine disease from Q4 of 2025.

The report, produced by Equine Infectious Disease Surveillance, includes advice on rule changes for equine influenza vaccination.

Statistics and maps detail recent outbreaks of equine herpes virus, equine influenza, equine strangles and equine grass sickness. A series of laboratory reports provides data on virology, bacteriology, parasitology and toxicosis.

This issue also features a case study of orthoflavivus-associated neurological disease in a horse in the UK. 

Click here for more...
News Shorts
RCVS annual renewal fee for vets due

RCVS' annual renewal fee for veterinary surgeons is now due. Vets must pay their renewal fee before Wednesday, 1 April 2026.

This year's standard annual fee has increased to 431 from last year's 418. This is an approximately three per cent increase, as approved by RCVS Council and the Privy Council.

Tshidi Gardner, RCVS treasurer, said: "The small fee increase will be used to help deliver both our everyday activities and our new ambitious Strategic Plan, which includes aims such as achieving new legislation, reviewing the Codes of Professional Conduct and supporting guidance, and continuing to support the professions through activities such as the Mind Matters Initiative, RCVS Academy and career development."

A full breakdown of the new fees is on the RCVS website. Information about tax relief is available on the UK government website.